Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
Clinical trial NCT05717738 · UNKNOWN
Trial details
- NCT number
- NCT05717738
- Sponsor
- Tongji Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-20
- Primary completion
- 2023-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.